NYSCF - Robertson Stem Cell Investigator and NYSCF - Robertson Stem Cell Prize Awardee Dr. Feng Zhang, the Broad Institute of Harvard and MIT, published his latest work expanding, modifying, and improving the CRISPR gene editing system.
The research, published in Nature Biotechnology, describes the ability to create CRISPR RNA that can be used to simplify multi-target genome editing. The scientists demonstrated this new tool by editing four genes in mammalian cells and three genes in the mouse brain, simultaneously.
Gene editing technologies have opened up an entirely new arm of scientific research. The ability to modify multiple genes at one time is extremely useful for researching and ultimately, treating complex multi-gene conditions and diseases.